Related content

The role of mineralocorticoid receptor antagonists in the treatment of cardiac failure

By Funder John W  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 1963-1969

Informa Healthcare

Access to resources Recommend Favorite

NK 1 (substance P) receptor antagonists - why are they not analgesic in humans?

By Hill R.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 7, 2000-07 ,pp. : 244-246

Elsevier

Access to resources Recommend Favorite

Targeting the mineralocorticoid receptor in cardiovascular disease

By Young Morag J  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 3, 2013-03 ,pp. : 321-331

Informa Healthcare

Access to resources Recommend Favorite

The brain mineralocorticoid receptor: greedy for ligand, mysterious in function

By Reul J.M.H.M.   Gesing A.   Droste S.   Stec I.S.M.   Weber A.   Bachmann C.   Bilang-Bleuel A.   Holsboer F.   Linthorst A.C.E.  

European Journal of Pharmacology, Vol. 405, Iss. 1, 2000-09 ,pp. : 235-249

Elsevier

Access to resources Recommend Favorite

Molecular Basis of Mineralocorticoid Receptor Action in the Nervous System

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1163-1174

Bentham Science Publishers

Access to resources Recommend Favorite